Skip to main content
48°
Rain Shower
Site search
Search
Menu
Search
Subscribe
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
Contact Us
Subscribe
News
East Greenwich Pendulum
Kent County Daily Times
Narragansett Times
NK Standard-Times
Sports
Features
Special Sections
Local Guide
Local Events
Markets & Stocks
Weather
League of Women Voters SRI
League of Women Voters WS
Classifieds
Place ad
Legal Notices
Place Kent Legal
Place SRI Class Legal
Search SRI Legals
Search Kent Legals
Obituaries
Subscribe
E-Edition
Community Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Evolent Health Inc Cl A Com
(NY:
EVH
)
11.59
+0.28 (+2.48%)
Official Closing Price
Updated: 7:00 PM EST, Nov 21, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Evolent Health Inc Cl A Com
< Previous
1
2
3
4
Next >
Why MercadoLibre Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session
February 23, 2024
Shares of MercadoLibre, Inc. (NASDAQ: MELI) fell sharply during Friday’s session after the company reported fourth-quarter financial results.
Via
Benzinga
Analyst Scoreboard: 4 Ratings For Evolent Health
February 23, 2024
Via
Benzinga
Evolent Health (EVH) Q4 2023 Earnings Call Transcript
February 23, 2024
EVH earnings call for the period ending December 31, 2023.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Evolent Health's Earnings: A Preview
February 21, 2024
Via
Benzinga
Analyst Expectations for Evolent Health's Future
December 06, 2023
Via
Benzinga
30 US States Pause Medicaid Disenrollment Due To Technical Glitch
September 22, 2023
The U.S.
Via
Benzinga
Evolent Health (EVH) Q2 2023 Earnings Call Transcript
August 02, 2023
EVH earnings call for the period ending June 30, 2023.
Via
The Motley Fool
12 Health Care Stocks Moving In Thursday's After-Market Session
February 22, 2024
Via
Benzinga
Why Daktronics Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
December 05, 2023
Shares of Daktronics, Inc. (NASDAQ: DAKT) moved lower during Tuesday’s session following weak quarterly results.
Via
Benzinga
Are You A Trader Or Investor: Biotech Momentum Is Picking Up
November 20, 2023
ETFs have not helped as portfolio fillers but they can identify trends. We should play this rally out of a biotech bear market.
Via
Talk Markets
Topics
ETFs
Earnings Outlook For Evolent Health
August 01, 2023
Via
Benzinga
Analyst Ratings for Evolent Health
June 26, 2023
Via
Benzinga
Evolent Health (EVH) Q1 2023 Earnings Call Transcript
May 04, 2023
EVH earnings call for the period ending March 31, 2023.
Via
The Motley Fool
Recap: Evolent Health Q1 Earnings
May 03, 2023
Via
Benzinga
Expedia Group, Gartner, Cloudflare, Cardinal Health And Other Big Stocks Moving Higher On Friday
November 03, 2023
U.S. stocks traded higher, with the Dow Jones gaining around 200 points on Friday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Evolent Health (EVH) Q3 2023 Earnings Call Transcript
November 03, 2023
EVH earnings call for the period ending September 30, 2023.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Growing Number of Industries Realize the Urgency for Ransomware Protection
July 12, 2023
EQNX::TICKER_START (NASDAQ:HCTI),(NASDAQ:HCAT),(NYSE:EVH),(NASDAQ:DH),(NASDAQ:NXGN) EQNX::TICKER_END
Via
FinancialNewsMedia
Evolent Health (EVH) Q4 2022 Earnings Call Transcript
February 22, 2023
EVH earnings call for the period ending December 31, 2022.
Via
The Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For October 16, 2023
October 16, 2023
Via
Benzinga
Market Mixes It Up With A Broad Rally
June 05, 2023
Biotech stocks remain sluggish but the longer-term outlook for breakthrough therapies - gene therapy, obesity, CNS, RNA - remain positive.
Via
Talk Markets
Cowen & Co. Maintains Outperform Rating for Evolent Health: Here's What You Need To Know
January 30, 2023
Via
Benzinga
Small & Mid Cap Life Science Stock Portfolio: Some Good Picks In A Stalled Sector
May 01, 2023
A pivotal week looks to be shaping up with the usual macro concerns arising, such as a Fed meeting and big earnings waiting just around the corner. One possible path to help navigate around these macro...
Via
Talk Markets
Benzinga's Top Ratings Upgrades, Downgrades For April 12, 2023
April 12, 2023
Via
Benzinga
Biotech And Life Science Trades: Q1 2023 Performance By The Numbers
April 01, 2023
Despite a strong month and a great finish to the quarter, many traders remain cautious about the market. It’s been a volatile time after the collapse of Silicon Valley Bank, but the first quarter of...
Via
Talk Markets
Evolent Health Q4 Top-Line Beats Expectation, Analyst Points To Visible Growth Outlook
February 23, 2023
Via
Benzinga
SMID Cap Life Science Update: Are You An Investor Or Trader?
February 20, 2023
Despite choppy trading, there is an upward tilt to life science stocks since the 9/26/22 lows.
Via
Talk Markets
When Small Cap Biotechs Lose Momentum: Are You An Investor Or A Trader?
February 05, 2023
A few small cap biotechs lost momentum last week so now might be the time to take profits. But many of these stocks are favored because of their core technology and favored by funds; time to buy?
Via
Talk Markets
Foot Locker, Ross Stores, Palo Alto Networks, And Other Big Gainers From Friday
November 21, 2022
U.S. stocks closed higher on Friday, with the Dow Jones gaining around 200 points. Here is the list of some big stocks recording gains in the previous session.
Via
Benzinga
Why InMed Pharmaceuticals Shares Tumbled 28%; Here Are 67 Biggest Movers From Friday
November 21, 2022
Gainers AGBA Group Holding Limited (NASDAQ: AGBA) gained 50.7% to close at $6.78 on Friday.
Via
Benzinga
This Analyst Is Bullish On Evolent Health's Recent Deal, Calls 'Highly Strategic Acquisition'
November 18, 2022
Via
Benzinga
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.